None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Males and females equal to or more than 20 years and less than 65 years of age 2.Healthy males and females with no treatment 3.Subjects equal to or more than 25 and less than 30 kg/m^2 of BMI at the pre-study 4.VFA level is above 80 cm^2 5.Subjects who recognize the object and contents of the study and submit the written informed consent
Exclusion criteria
Exclusion criteria: 1.Subjects who have marked impairment of liver, kidney, heart, lung, endocrine, metabolism, nerve, or consciousness, or have DM 2.Subjects who have historical disease of circulatory system disease 3.Subjects who use drugs of glycometabolism, lipidmetabolism, or reducing high blood pressure 4.Subjects who regularly use drugs, health foods, supplements which are suggested causal relationship from the study except who agree to quit taking them 5.Subjects who have allergy related to the test foods 6.Subjects who feel bad mood by blood collection in past 7.Subjects who donated 200 mL or more of blood within a month prior to the study. 8.Subjects who participate in other clinical trials within the last 4 weeks prior to the current study 9.Heavy dinkers or heavy smokers 10.Subjects whose eating habits are extremely irregular 11.Pregnant and lactating female, or who wish to get pregnant during the study period. 12.Subjects who can not agree with preliminary explanation. 13.Subjects who are ineligible due to physician's judgment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visceral fat area, at 8 and 12 weeks after intake | — |
Countries
Japan
Contacts
New drug research center, Inc. Clinical Research Dept.